Haoyu Pan

机构：Zhejiang Chinese Medical University, Sir Run Run Shaw Hospital, Zhejiang Cancer Hospital, Zhejiang Lab, Center for Special Minimally Invasive and Robotic Surgery, Zhejiang University

发表论文 9 篇 · 总被引 83 次 · h-index 4

代表论文

• Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation (2023 · Journal of Experimental & Clinical Cancer Research · 被引 31)
• Noninvasive prognostic classification of ITH in HCC with multi-omics insights and therapeutic implications (2025 · Science Advances · 被引 22)
• Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers (2024 · Advanced Science · 被引 19)
• Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis (2023 · Cancer Gene Therapy · 被引 9)
• A Novel MPT ‐Driven Necrosis‐Related lncRNA Signature for Prognostic Prediction in Hepatocellular Carcinoma: Validation Using Organoids (2025 · Cancer Medicine · 被引 2)
• Targeting LDL Dysregulation for Intrahepatic Cholangiocarcinoma Prevention: Clinical and Translational Evidence from Lipid-Lowering Drug Mendelian Randomization (2025 · SSRN Electronic Journal)